Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)
Status:
Withdrawn
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Gene transfer is a process in which the DNA (genetic material) of certain cells is changed.
In this study, gene transfer will be performed on a type of white blood cell (called T cells)
to recognize leukemia cells in the same person the T cells were collected from.
The goal of this clinical research study is to learn if it is safe to give these
genetically-changed T cells back to patients with CLL/SLL. Researchers also want to learn if
these cells can help to attack CLL/SLL cells.